CEO and Fund Manager, Renaissance Venture Capital Fund
Co-Founder and CEO, DNAnexus
Medical College of Wisconsin director of research commercialization
Professor, Michigan State University
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Serial Entrepreneur and Investor
Senior health advisor for Esri
Founder and CEO, Acme Packet
Entry | Author | Date | Location | |
---|---|---|---|---|
Aimmune May Seek Up To $115M in IPO for Allergy Therapy Drug | David Holley | 07/07/15 | San Francisco | |
Page 1 of 1 | ||||